Gourt > Health > Medicine > Medical Specialties > Obstetrics and Gynecology > Obstetrics > DES Syndrome
In medicine, the term syndrome is the association of several clinically recognizable features, signs, symptoms, phenomena or characteristics which often occur together, so that the presence of one feature alerts the physician to the presence of the others. In recent decades the term has been used outside of medicine to refer to a combination of phenomena seen in association.
The term syndrome derives from the Greek and means literally "run together," as the features do. The term syndrome is most often used when the reason that the features occur together (pathophysiology) has not yet been discovered. A familiar syndrome name often continues to be used even after an underlying cause has been found. Many syndromes are named after the physicians credited with first reporting the association; these are "eponymous" syndromes. Otherwise, disease features or presumed causes, as well as references to geography, history or poetry, can lend their names to syndromes.
AIDS, a case study
A recent case study is Acquired Immune Deficiency Syndrome (AIDS), so named as most syndromal immune deficiencies are either inborn or secondary to hematological disease. AIDS was originally termed "Gay Related Immune Disease" (or GRID), a name which was revised as the disease turned out to also affect heterosexuals. Several years passed after the recognition of AIDS before HIV (human immunodeficiency virus) was first described, finally explaining the hitherto mysterious "syndrome". More on [ Syndrome ]
Chronic Illness
Infertility :: Reproductive Health
Support Groups :: Women's Health
Using Robotic Surgery to Treat Cancer: Penn Expands Robotic Gynecologic Surgery Program
New advances in robotic-assisted surgery are shortening the recovery time, reducing pain and letting women get back to their lives in record time. Penn’s robotic gynecologic surgery program continues to grow and is now available at all three UPHS hospitals.
Gyn Onc Services Move to Perelman Center for Advanced Medicine
Opening this summer, the Perelman Center is a state-of-the-art, 360,000+ square foot outpatient facility designed to create an ideal environment for patient-focused care and collaboration among health care professionals. The Abramson Cancer Center of the University of Pennsylvania will be one of the first tenants to move into the Perelman Center this summer.
OncoLife Survivorship Care Plan
Oncolink® has created an individualizedplan of care based on the Institute of Medicine recommendations for cancer survivors. This free program provides cancer survivors with information regarding the health risks they face as a result of cancer therapies.
DES Action USA - Non-profit organization dedicated to informing the public about DES (diethylstilbestrol) and helping DES-exposed individuals. Publishes on various aspects of DES exposure and provide a link between DES-exposed people, researchers, and the medical community.
DES Cancer Network - Organization that addresses the special needs of women who have clear cell adenocarcinoma of the vagina and/or cervix, a rare cancer linked to exposure to diethylstilbestrol before birth.
Meta Description: [ The DES Cancer Network is an organization that addresses
the special needs of women who have had clear cell adenocarcinoma
of the vagina and/or cervix; a cancer linked to exposure to
DES before birth. As of January 1997, approximately 680 women in the
... ]
Health.nsw.gov - DES - Information about effects and symptoms of DES.
Images of Uterine Deformity Caused by Diethylstilbestrol Exposure - Two uterine images of a 35 year old female with known history of exposure to DES. Department of Radiology, Case Western Reserve University, Cleveland, Ohio.
Questions and Answers About DES - Information from the National Cancer Institute about DES (diethylstilbestrol) and its potential effects on mothers who have taken the drug and daughters and sons who were exposed to it in utero.
Meta Description: [ DES: Questions and Answers ]
Registry for Research on Hormonal Transplacental Carcinogenesis - International research registry of cancer patients with clear cell adenocarcinoma of the vagina and/or cervix or other specific gynecologic cancers who may or may not have been exposed to diethylstilbestrol (DES) or other synthetic hormones in utero.
Testimony on DES - Stephanie Kanarek's testimony before the US House Judiciary Committee on the effects of diethylstilbestrol.
| Angelman France Fête des voisins mai 2007 | |
| Next Video | |
